Open access · CC-BY
via OpenAlex
Chronic dietary supplementation with nicotinamide riboside reduces sleep need in the laboratory mouse
Priyanka N. Bushana, Michelle A. Schmidt, Michael J. Rempe, Barbara A. Sorg, Jonathan P. Wisor
SLEEP Advances · 2023 · ▲ 3 citations
Abstract
Non-rapid eye movement sleep (NREMS) is accompanied by a reduction in cerebral glucose utilization. Enabling this metabolic change may be a central function of sleep. Since the reduction in glucose metabolism is inevitably accompanied by deceleration of downstream oxidation/reduction reactions involving nicotinamide adenine dinucleotide (NAD), we hypothesized a role for NAD in regulating the homeostatic dynamics of sleep at the biochemical level. We applied dietary nicotinamide riboside (NR), a NAD precursor, in a protocol known to improve neurological outcome measures in mice. Long-term (6-10 weeks) dietary supplementation with NR reduced the time that mice spent in NREMS by 17 percent and accelerated the rate of discharge of sleep need according to a mathematical model of sleep homeostasis (Process S). These findings suggest that increasing redox capacity by increasing nicotinamide availability reduces sleep need and increases the cortical capacity for energetically demanding high-frequency oscillations. In turn, this work demonstrates the impact of redox substrates on cortical circuit properties related to fatigue and sleep drive, implicating redox reactions in the homeostatic dynamics of cortical network events across sleep-wake cycles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/sleepadvances/zpad044
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Bushana, P.N., Schmidt, M.A., Rempe, M.J., Sorg, B.A., & Wisor, J.P. (2023). Chronic dietary supplementation with nicotinamide riboside reduces sleep need in the laboratory mouse. <em>SLEEP Advances</em>. https://doi.org/10.1093/sleepadvances/zpad044
Vancouver
Bushana PN, Schmidt MA, Rempe MJ, Sorg BA, Wisor JP. Chronic dietary supplementation with nicotinamide riboside reduces sleep need in the laboratory mouse. SLEEP Advances. 2023. doi:10.1093/sleepadvances/zpad044.
BibTeX
@article{priyanka2023Chroni,
title = {Chronic dietary supplementation with nicotinamide riboside reduces sleep need in the laboratory mouse},
author = {Priyanka N. Bushana and Michelle A. Schmidt and Michael J. Rempe and Barbara A. Sorg and Jonathan P. Wisor},
journal = {SLEEP Advances},
year = {2023},
doi = {10.1093/sleepadvances/zpad044},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advanced Functional Materials 2025
Open access · OA
Nanopore Identification of Nicotinamide Adenine Nucleotide and Its Derivatives
Journal of Ovarian Research 2025
Open access · CC-BY
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA
Potential significance of NAD+ biology translational research in super-aged Japan
Aging Cell 2022
Open access · CC-BY
Oral nicotinamide riboside raises NAD + and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Current Nutrition Reports 2023
Open access · OA
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
Frontiers in Physiology 2021
Open access · CC-BY